nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Peptide GPCRs—GNRHR—adrenal gland cancer	0.128	0.151	CbGpPWpGaD
Plerixafor—CXCR4—Peptide GPCRs—TSHR—adrenal gland cancer	0.0684	0.0804	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—IGF2—adrenal gland cancer	0.0524	0.0616	CbGpPWpGaD
Plerixafor—CXCR4—adrenal cortex—adrenal gland cancer	0.0445	0.298	CbGeAlD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.0428	0.0503	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.0404	0.0475	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—CDC42—adrenal gland cancer	0.0376	0.0442	CbGpPWpGaD
Plerixafor—CXCR4—cardiac atrium—adrenal gland cancer	0.0368	0.246	CbGeAlD
Plerixafor—CXCR4—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.0366	0.043	CbGpPWpGaD
Plerixafor—CXCR4—pituitary gland—adrenal gland cancer	0.036	0.241	CbGeAlD
Plerixafor—CXCR4—adrenal gland—adrenal gland cancer	0.0321	0.215	CbGeAlD
Plerixafor—CXCR4—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0308	0.0362	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—BAD—adrenal gland cancer	0.0263	0.0309	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.0242	0.0285	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.0216	0.0254	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0184	0.0217	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0174	0.0205	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—TSHR—adrenal gland cancer	0.0164	0.0193	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0158	0.0186	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.0158	0.0186	CbGpPWpGaD
Plerixafor—CXCR4—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.0126	0.0148	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SH3KBP1—adrenal gland cancer	0.0124	0.0146	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ZNRF3—adrenal gland cancer	0.0116	0.0137	CbGpPWpGaD
Plerixafor—CXCR4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.0106	0.0125	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.0104	0.0123	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00956	0.0112	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00946	0.0111	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00933	0.011	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00929	0.0109	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00868	0.0102	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00845	0.00994	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00844	0.00992	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00816	0.00959	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SPRY2—adrenal gland cancer	0.0073	0.00858	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MEN1—adrenal gland cancer	0.00669	0.00787	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—POMC—adrenal gland cancer	0.00644	0.00757	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00605	0.00712	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00565	0.00665	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00559	0.00657	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0054	0.00635	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00514	0.00604	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00511	0.00601	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRKACA—adrenal gland cancer	0.00511	0.006	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TSHR—adrenal gland cancer	0.00498	0.00586	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00491	0.00577	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MEN1—adrenal gland cancer	0.00468	0.00551	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CDC42—adrenal gland cancer	0.00433	0.00509	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00364	0.00428	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00358	0.0042	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TERT—adrenal gland cancer	0.00348	0.00409	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—adrenal gland cancer	0.0033	0.00388	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CDC42—adrenal gland cancer	0.00303	0.00357	CbGpPWpGaD
Plerixafor—CXCR4—Disease—BAD—adrenal gland cancer	0.00302	0.00355	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF2—adrenal gland cancer	0.00292	0.00344	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNAS—adrenal gland cancer	0.0029	0.00341	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1R—adrenal gland cancer	0.00283	0.00332	CbGpPWpGaD
Plerixafor—CXCR4—Disease—BRAF—adrenal gland cancer	0.00275	0.00324	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TERT—adrenal gland cancer	0.00243	0.00286	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—adrenal gland cancer	0.00222	0.00261	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BAD—adrenal gland cancer	0.00212	0.00249	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CTNNB1—adrenal gland cancer	0.00199	0.00234	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—adrenal gland cancer	0.00195	0.00229	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BRAF—adrenal gland cancer	0.00193	0.00227	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—EGFR—adrenal gland cancer	0.00187	0.0022	CbGpPWpGaD
Plerixafor—CXCR4—Disease—EGFR—adrenal gland cancer	0.00158	0.00185	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00139	0.00164	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—EGFR—adrenal gland cancer	0.0011	0.0013	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—adrenal gland cancer	0.000926	0.00109	CbGpPWpGaD
